Morelli
Does the use of the short-acting β-blocker esmolol effectively control heart rate (HR) in patients with septic shock?
Continue reading »A compendium of critical appraisals in Intensive Care Medicine research and related specialties
Does the use of the short-acting β-blocker esmolol effectively control heart rate (HR) in patients with septic shock?
Continue reading »In patients with septic shock, does Activated Protein C (also known as drotrecogin alfa or DrotAA) compared with placebo reduce mortality?
Continue reading »In patients with septic shock, does blood transfusion at a lower or higher haemoglobin threshold improve mortality?
Continue reading »In adult patients with septic shock, does early goal-directed therapy (EGDT) compared with standard therapy reduce mortality at 90 days?
Continue reading »In adults with severe sepsis or septic shock, does the use of early goal-directed therapy (EGDT) reduce the mortality?
Continue reading »Does a delay in antibiotic administration in patients with septic shock result in an increased mortality?
Continue reading »In patients with septic shock, is mortality affected by the use of adrenaline (epinephrine) alone in comparison to noradrenaline ± dobutamine?
Continue reading »In adult patients with sepsis, does protocol-based care compared to usual care reduce death within 60 days?
Continue reading »